NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 135 filers reported holding NEWLINK GENETICS CORP in Q1 2017. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $0 | – | 40 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 40 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 40 | 0.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 40 | -66.7% | 0.00% | – |
Q2 2016 | $1,000 | -50.0% | 120 | 0.0% | 0.00% | – |
Q1 2016 | $2,000 | -98.8% | 120 | -97.3% | 0.00% | -100.0% |
Q4 2015 | $161,000 | +0.6% | 4,455 | -0.7% | 0.01% | -16.7% |
Q3 2015 | $160,000 | -21.2% | 4,487 | -2.3% | 0.01% | -14.3% |
Q2 2015 | $203,000 | – | 4,591 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FT Options LLC | 21,900 | $1,292,000 | 1.11% |
TIVERTON ASSET MANAGEMENT LLC | 288,807 | $18,215,000 | 0.77% |
Knoll Capital Management, LLC | 102,437 | $1,153,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 460,146 | $5,181,000 | 0.36% |
WALL STREET ASSOCIATES | 79,000 | $890,000 | 0.36% |
Endurant Capital Management LP | 62,491 | $704,000 | 0.24% |
FT Options LLC | 21,903 | $247,000 | 0.21% |
Virtus ETF Advisers LLC | 24,463 | $275,000 | 0.20% |
Orbimed Advisors | 1,581,506 | $17,808,000 | 0.19% |
HAP Trading, LLC | 227,728 | $2,564,000 | 0.15% |